Of note, CSF α-synuclein seeds have been demonstrated to effectively discriminate synucleopathies from tauopathies, particularly when combined with Nf-L and MRI measurements [43,44,45], and it is possible that tau aggregates could be effective as well. The gene discussed is NEFL; the disease is tauopathy.